Dynavax Technologies Corp (DVAX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Eddie J. Gray
Employees:
249
2929 SEVENTH STREET, SUITE 100, BERKELEY, CA 94710
5108485100

Dynavax Technologies Corp. is a clinical-stage biopharmaceutical company that uses toll-like receptor biology to discover and develop novel vaccines and therapeutics. The company's development programs are organized under its three areas of focus: vaccine adjuvants, cancer immunotherapy, and autoimmune and inflammatory diseases. Its lead product candidate is HEPLISAV, a Phase III investigational adult hepatitis B vaccine. The company's other products under pipeline are SD-101, DV1179 Autoimmune Disease and AZD1419 Asthma Therapy. Dynavax Technologies was founded by Lawrence M. Lichtenstein, Dennis A. Carson and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.

Data derived from most recent annual or quarterly report
Market Cap 1.54 Billion Shares Outstanding124.922 Million Avg 30-day Volume 2.503 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0.04
Price to Revenue9.7032 Debt to Equity3.0636 EBITDA-55.274 Million
Price to Book Value7.6959 Operating Margin-146.8733 Enterprise Value466.468 Million
Current Ratio3.746 EPS Growth0.639 Quick Ratio2.425
1 Yr BETA 1.5714 52-week High/Low 21.39 / 7.26 Profit Margin-161.6292
Operating Cash Flow Growth23.918 Altman Z-Score-3.9629 Free Cash Flow to Firm -85.471 Million
Earnings Report2022-08-04
View SEC Filings from DVAX instead.

View recent insider trading info

Funds Holding DVAX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DVAX BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-05-26:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-16:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
  • 8-K: filed on 2022-02-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-14:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-11-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-21:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-07-07:
    Item 1.01: Entry into a Material Definitive Agreement
  • 8-K: filed on 2021-07-01:
    Item 1.01: Entry into a Material Definitive Agreement
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    6 Thousand total shares from 1 transactions

    Exercise Derivative Conversion (M)

    6 Thousand total shares from 1 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    KISNER DANIEL L

    • Director
    27,857 2022-05-26 1

    RICCIARDI NATALE S

    • Director
    27,857 2022-05-26 1

    CANO FRANCIS

    • Director
    27,857 2022-05-26 2

    MYERS SCOTT DUNSETH

    • Director
    20,893 2022-05-26 3

    PHILLIPS PEGGY V

    • Director
    27,857 2022-05-26 2

    EASTLAND JULIA MARIE

    • Director
    27,857 2022-05-26 1

    HACK ANDREW A. F.

    • Director
    27,857 2022-05-26 3

    SUN ELAINE D

    • Director
    13,929 2022-05-26 3

    MACGREGOR BRENT

    • Director
    27,857 2022-05-26 1

    PARADISO PETER R.

    • Director
    27,857 2022-05-26 1

    BURGESS JUSTIN PRINCIPAL ACCOUNTING OFFICER

    • Officer
    13,708 2022-05-16 5

    NOVACK DAVID F PRESIDENT & COO

    • Officer
    223,288 2022-03-02 8

    JANSSEN ROBERT SENIOR VICE PRESIDENT

    • Officer
    93,450 2022-03-02 7

    SPENCER RYAN CEO AND DIRECTOR

    • Officer
    • Director
    743,084 2022-03-02 2

    MACDONALD KELLY SVP AND CFO

    • Officer
    106,500 2022-02-10 1

    OSTRACH MICHAEL S SENIOR VICE PRESIDENT

    • Officer
    0 2021-02-03 0

    ORONSKY ARNOLD L

    • Director
    0 2020-05-28 0

    JOHNSON DAVID LOUIS VICE PRESIDENT

    • Officer
    48,380 2020-03-13 0

    COFFMAN ROBERT SENIOR VICE PRESIDENT

    • Officer
    77,768 2019-06-02 0

    GRAY EDDIE CEO AND DIRECTOR

    • Officer
    • Director
    304,597 2019-06-02 0

    CARSON DENNIS

    • Director
    0 2019-05-30 0

    BREGE LAURA

    • Director
    0 2019-05-30 0

    PLOTKIN STANLEY A

    • Director
    0 2017-06-02 0

    GILBERT DENISE

    • Director
    0 2014-05-28 0

    DINA DINO

    • Director
    0 2014-05-28 0

    TUCK STEPHEN F VP, GLOBAL TECHNICAL OPS

    • Officer
    0 2013-02-05 0

    LEW JENNIFER VP, FINANCE & PAO

    • Officer
    0 2013-02-05 0

    MARTIN J TYLER PRESIDENT, CMO & DIRECTOR

    • Officer
    • Director
    222,089 2012-11-16 0

    KESSEL MARK

    • Director
    3,031,431 2012-10-16 0

    LARSON CHRISTINE R VP AND CHIEF FINANCIAL OFFICER

    • Officer
    0 2012-08-13 0

    JANOWICZ ZBIGNIEW CEO DYNAVAX EUROPE

    • Officer
    0 2012-03-09 0

    LAWRENCE DAVID M

    • Director
    0 2010-05-12 0

    BUC NANCY L

    • Director
    0 2010-05-12 0

    SYMPHONY CAPITAL PARTNERS LP

    SYMPHONY CAPITAL GP, L.P.

    SYMPHONY GP, LLC

    SYMPHONY STRATEGIC PARTNERS LLC

    TARANTO HARRI V

    • Director
    • 10% Owner
    • SEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKS
    9,031,431 2010-04-16 0

    BVF PARTNERS L P/IL

    BIOTECHNOLOGY VALUE FUND L P

    BIOTECHNOLOGY VALUE FUND II LP

    BVF INVESTMENTS LLC

    LAMPERT MARK N

    BVF INC/IL

    • 10% Owner
    • DIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNER
    17,115,404 2009-09-10 0

    BVF PARTNERS L P/IL

    BIOTECHNOLOGY VALUE FUND L P

    BIOTECHNOLOGY VALUE FUND II LP

    BVF INVESTMENTS LLC

    BVF INC/IL

    • 10% Owner
    • INDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERINDIRECT BENEFICIAL OWNER
    25,254,628 2009-06-03 0

    SMELTZER DEBORAH A VP, OPERATIONS & CFO

    • Officer
    0 2009-03-10 0

    FLYNN JAMES E

    DEERFIELD CAPITAL LP

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    DEERFIELD MANAGEMENT CO /NY

    DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

    DEERFIELD PRIVATE DESIGAN FUND L P

    DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.

    • 10% Owner
    No longer subject to file 2008-10-22 0

    SANDERS MARTIN E EVP AND CDO

    • Officer
    0 2008-10-03 0

    FLYNN JAMES E

    DEERFIELD CAPITAL LP

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    DEERFIELD MANAGEMENT CO /NY

    DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

    DEERFIELD PRIVATE DESIGAN FUND L P

    • 10% Owner
    1,250,000 2007-07-18 0

    DEERFIELD PRIVATE DESIGAN FUND L P

    • 10% Owner
    0 2007-07-18 0

    DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.

    • 10% Owner
    0 2007-07-18 0

    HENN TIMOTHY G VP, FINANCE & ADMINISTRATION

    • Officer
    20,000 2007-02-02 0

    VAN NEST GARY A VP, PRECLINICAL RESEARCH

    • Officer
    25,000 2007-02-02 0

    JANNEY DANIEL

    • NO LONGER A DIRECTOR
    10,030 2006-11-14 0

    FLYNN JAMES E

    DEERFIELD CAPITAL LP

    DEERFIELD PARTNERS, LP

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    DEERFIELD MANAGEMENT CO /NY

    DEERFIELD INTERNATIONAL LTD

    DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

    • 10% Owner
    • POSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUP
    4,851,538 2006-10-04 0

    LESCHLY JAN

    • Director
    10,000 2006-06-14 0

    FLYNN JAMES E

    DEERFIELD CAPITAL LP

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    DEERFIELD MANAGEMENT CO /NY

    DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

    • 10% Owner
    • POSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUP
    328,447 2006-05-15 0

    LEVITT DANIEL J VICE PRESIDENT

    • Officer
    50,000 2006-02-14 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    RICCIARDI NATALE S - Director

    2022-05-27 17:00:51 -0400 2022-05-26 A 5,357 a 5,357 direct

    KISNER DANIEL L - Director

    2022-05-27 17:00:55 -0400 2022-05-26 A 22,500 a 22,500 direct

    KISNER DANIEL L - Director

    2022-05-27 17:00:55 -0400 2022-05-26 A 5,357 a 5,357 direct

    HACK ANDREW A. F. - Director

    2022-05-27 17:29:43 -0400 2022-05-26 A 22,500 a 22,500 direct

    HACK ANDREW A. F. - Director

    2022-05-27 17:29:43 -0400 2022-05-26 A 5,357 a 5,357 direct

    SUN ELAINE D - Director

    2022-05-27 17:01:59 -0400 2022-05-26 A 11,250 a 11,250 direct

    SUN ELAINE D - Director

    2022-05-27 17:01:59 -0400 2022-05-26 A 2,679 a 2,679 direct

    PARADISO PETER R. - Director

    2022-05-27 17:01:01 -0400 2022-05-26 A 22,500 a 22,500 direct

    PARADISO PETER R. - Director

    2022-05-27 17:01:01 -0400 2022-05-26 A 5,357 a 5,357 direct

    CANO FRANCIS - Director

    2022-05-27 17:01:06 -0400 2022-05-26 A 22,500 a 22,500 direct

    CANO FRANCIS - Director

    2022-05-27 17:01:06 -0400 2022-05-26 A 5,357 a 5,357 direct

    RICCIARDI NATALE S - Director

    2022-05-27 17:00:51 -0400 2022-05-26 A 22,500 a 22,500 direct

    MACGREGOR BRENT - Director

    2022-05-27 17:00:38 -0400 2022-05-26 A 22,500 a 22,500 direct

    MACGREGOR BRENT - Director

    2022-05-27 17:00:38 -0400 2022-05-26 A 5,357 a 5,357 direct

    PHILLIPS PEGGY V - Director

    2022-05-27 17:01:00 -0400 2022-05-26 A 22,500 a 22,500 direct

    PHILLIPS PEGGY V - Director

    2022-05-27 17:01:00 -0400 2022-05-26 A 5,357 a 5,357 direct

    EASTLAND JULIA MARIE - Director

    2022-05-27 17:01:34 -0400 2022-05-26 A 22,500 a 22,500 direct

    EASTLAND JULIA MARIE - Director

    2022-05-27 17:01:34 -0400 2022-05-26 A 5,357 a 5,357 direct

    MYERS SCOTT DUNSETH - Director

    2022-05-27 17:01:45 -0400 2022-05-26 A 16,875 a 16,875 direct

    MYERS SCOTT DUNSETH - Director

    2022-05-27 17:01:45 -0400 2022-05-26 A 4,018 a 4,018 direct

    BURGESS JUSTIN - Officer PRINCIPAL ACCOUNTING OFFICER

    2022-05-18 18:16:54 -0400 2022-05-17 S 6,000 $10.00 d 3,854 direct -3.3989 4.4723 5.4562 5 -3.3989 2

    BURGESS JUSTIN - Officer PRINCIPAL ACCOUNTING OFFICER

    2022-05-18 18:16:54 -0400 2022-05-16 M 6,000 a 9,854 direct -3.3989 4.4723 5.4562 5 -3.3989 2

    BURGESS JUSTIN - Officer PRINCIPAL ACCOUNTING OFFICER

    2022-05-18 18:16:54 -0400 2022-05-16 M 6,000 d 0 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund DVAX -94175.0 shares, $-1154585.5 2022-02-28 N-PORT
    RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund DVAX -7739.0 shares, $-100374.83 2022-01-31 N-PORT
    JNL Series Trust- JNL Multi-Manager Alternative Fund DVAX -150029.0 shares, $-1626314.36 2022-03-31 N-PORT
    LAZARD FUNDS INC- Lazard Enhanced Opportunities Portfolio DVAX -97365.0 shares, $-1055436.6 2022-03-31 N-PORT

    Elevate your investments